Waaree Energies Ltd (WAAREEENER) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported its highest-ever order book of INR 61,500 crores, a significant increase from INR 50,000 crores in the previous quarter, driven by INR 16,000 crores in new orders, signaling strong market confidence and demand.
- The retail business segment demonstrated exceptional growth, with revenue more than doubling year-on-year to INR 2,289 crores, and is projected to become a INR 10,000 crore business for the full fiscal year.
- The company faced margin compression during the quarter, attributed to a combination of rising global raw material costs, a softer export mix due to shipment delays, and capacity running ahead of dispatches, which are expected to normalize in the second half of the year.
- Strategic expansion projects are proceeding on schedule, including the commissioning of a 3 GW module capacity, commencement of a 5.15 GWh BESS container production line, and the acquisition of a 55% stake in Associated Power Structures to enter the T&D sector.
- The company reaffirmed its full-year operating EBITDA guidance of INR 7,000 to INR 7,700 crores for FY27, citing strong demand tailwinds, a record order book, compounding growth in retail and e-commerce, and timely execution of expansion projects.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.